
Cartesian Growth (RENEW) | Stock Overview & Key Data
Cartesian Growth Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $147.87 on July 23, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Cartesian Growth RENEW | 1.85B Small-cap | -0.08% | 0.45% | 10.13% | 25.17% | 22.61% | 9.82% | 1,630.24% | 1,956.23% |
SILVERspac SLVR | 753.75M Small-cap | 9.42% | 10.11% | 40.20% | 42.57% | 54.01% | 54.45% | 239.05% | 239.40% |
Ares Acquisition AACT | 705.82M Small-cap | -0.09% | 0.71% | 1.24% | 3.26% | 3.92% | 6.05% | 12.66% | 12.66% |
EQV Ventures EQV.UN | 481.38M Small-cap | 1.89% | -0.18% | 4.05% | 6.40% | 5.88% | 8.65% | 8.65% | 8.65% |
Agriculture ANSC | 469.20M Small-cap | 0.09% | 0.37% | 1.40% | 3.42% | 3.81% | 5.43% | 7.94% | 7.94% |
Eqv Ventures EQV | 463.55M Small-cap | 0.00% | -0.76% | 1.56% | 3.90% | 4.31% | 4.84% | 4.84% | 4.84% |
Ownership & Short Interest
Cartesian Growth Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Cartesian Growth would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is RENEW's 52-week high and low?
- In the last 52 weeks, Cartesian Growth reached a high of $147.87 (on July 23, 2025) and a low of $110.08 (on January 13, 2025).
- What is the market cap and P/E ratio for RENEW?
- Curious about Cartesian Growth's size and valuation? Its market capitalization stands at 1.85B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does RENEW pay dividends? If so, what's the yield?
- As for dividends, Cartesian Growth isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Cartesian Growth's main competitors or similar companies to consider before investing?
When looking at Cartesian Growth, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return SILVERspac
SLVR753.75M Financial Services Shell Companies 54.45% 239.05% Ares Acquisition
AACT705.82M Financial Services Shell Companies 6.05% 12.66% EQV Ventures
EQV.UN481.38M Financial Services Shell Companies 8.65% 8.65% Agriculture
ANSC469.20M Financial Services Shell Companies 5.43% 7.94% Eqv Ventures
EQV463.55M Financial Services Shell Companies 4.84% 4.84% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cartesian Growth Corporation II? (e.g., ROE, Debt/Equity)
- To get a sense of Cartesian Growth's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.76%, the Debt to Equity ratio from the most recent quarter is 0.10, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for RENEW?
- Looking at Cartesian Growth's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of -69.50%.
- How much of RENEW stock is held by insiders and institutions?
- Wondering who owns Cartesian Growth stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.